Effect of Pancreas Transplantation on Liver Carbohydrate Metabolism in Streptozotocin Diabetic Rats by Brekke, I. B. et al.
Brekke, £. Schmidt and F. W. Schmidt: Pancreas transplantation in streptozotocin diabetic rats g \
J. Clin. Chem. Clin. Biochem.
Vol. 20,1982, pp. 81-84
Effect of Pancreas Transplantation on Liver Carbohydrate Metabolism
in Streptozotocin Diabetic Rats
By/. B. Brekke
Institute for Surgical Research, Rikshospitalet, The National Hospital, Oslo,Norway
Ellen Schmidt and F. W. Schmidt
Department for Gastroenterology and Hepatology, Medical School Hannover, FRG
(Received July 21/November 2,1981)
Summary: The failure of pancreas transplantation to normalize plasrna glucagon concentration and insulin: glucagon
balance in portal blood has recently been demonstrated on streptozotocin-diabetic rats. The same experimental
model was used in the present study to examine the effect of pancreas transplantation on liver carbohydrate metab-
olism. Twenty weeks after pancreas transplantation, the left hepatic lobe was removed for studies of several glycolytic
and gluconeogenic enzymes. Livers from nontransplanted diabetic rats showed decreased activities of glycolytic
enzymes and enhanced activities of gluconeogenic enzymes. In recipients of pancreas transplants, however, the activ-
ities of glycolytic and gluconeogenic enzymes did not differ from those observed in normal control rats.
It is concluded that the alterations of hepatic gluconeogenesis and glycolysis observed in streptozotocin-diabetic rats
are restored to normal by the pancreas transplant despite its failure to obviate hyperglucagonaemia.
Wirkung einer Pankreas-Transplantation auf den Kohlenhydratstoffwechsel der Leber
Streptozotocin-diabetischer Ratten
Zusammenfassung: Das Versagen einer Pankreas-Transplantation, die Glucagonkonzentration im Plasma und das
Insulin/Glucagon-Verhältnis im Portalblut zu normalisieren, wurde kürzlich an Streptozotocin-diabetischen Ratten
gezeigt. Das gleiche experimentelle Modell wurde in der vorliegenden Studie benutzt, um die Wirkung einer Pankreas-
Transplantation auf den Kohlenhydratstoffwechsel der Leber zu untersuchen. 20 Wochen nach Pankreas-Transplanta-
tion wurde der linke Lebeflappen zur Untersuchung verschiedener Enzyme der Glykolyse und Gluconeogenese ent-
fernt. Lebern nicht-transplantierter diabetischer Ratten zeigten eine verringerte Aktivität der Glykolyseenzyme und
eine erhöhte Aktivität von Enzymen der Gluconeogenese. In Pankreas-Transplantat-Empfängern unterschieden sich
jedoch die Aktivitäten der Glykolyseenzyme und der Enzyme der Gluconeogenese nicht von den bei normalen Kon-
trollratten beobachteten.
Es wird geschlossen, daß die bei Streptozotocin-diabetischen Ratten beobachteten Änderungen der Gluconeogenese
und Glykolyse in der Leber durch das Pankreastransplantat normalisiert werden, obwohl es versagt, der Hypergluca-
gonämie entgegenzuwirken.
Introduction activities of hepatic enzymes governing gluconeogenesis
- The liver is of central importance ih cärbohydrate metab- and ' 00^18 (4~7)·
olism, and insulin and glucagon are considered two of Earlier studies on pancreas transplantation have demon-
the major hormonal controls of hepatic glücose metab- strated sufficient insulin release from the transplant to
olism, on which they exert opposing actions (l , 2). The restore normoglycaemia and normal glücose tolerance
effect of both hormones involves changes in synthesis in streptozotocin-diabetic rats (8). However, the hyper-
and degradation of enzymes in the rrietabolic pathways ghicagonaemia of untreated diabetic rats is apparently
of glücose production and metabolism. Insulin deficiency not influenced by the transplantation, and the insulin
induced by streptozotocin or alloxan is associated with to glucagon ratio in portal blood of pancreas recipients
hyperglucagonaemia (3) and well defined changes in the is significantly decreased (9).
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By measuring the activities of several glucoregulatory
hepatic enzymes, the present study was undertaken to
examine the extent to which the pancreas transplant
may normalize diabetic alterations of hepatic gluconeo-
genesis and glycolysis,
Materials and Methods
Animals
Inbred male Wistariats were used (Kyoto/Nih, from Mtfllegaards
Breeding Centre, Denmark). They were fed commercial rat
pellets and water ad libitum. At about three months of age, dia-
betes was induced by streptozotocin, 65 mg/kg body weight,
given äs a single intravenous injection. 2-4 weeks later, diabetic
rats with stable blood glucose levels above 17 mmol/1 were
randomly divided into 2 groups:
One group was used äs diabetic controls while
the other group received duct-ligated pancreas transplants.
A third group of healthy litter mates seived äs non-diabetic con-
trols.
Procedures
The pancreas transplants were anastomosed to the abdominal
aorta and inferior caval vein äs previously described (8). Blood
glucose concentrations and body weights were recorded monthly.
Twenty weeks after transplantation, the animals were killed for
hepatic enzyme studies. Foliowing a 14-16 h fast they were
anaesthetized with sodium pentpbaibitai, 50 mg/kg body weight,
given intraperitoneally. The left hepatic lobe was removed,
chiiled on ice, weighed and stored at - 70 °C. Blood samples for
determination of immunoreactive insulin and glucagon were
drawn from the aorta. The samples were collected in heparinized
glass tubes chiiled in ice water. They were centrifuged at + 4 °C
and stored at - 20 °C until analysed.
Assay methods
Blood glucose was analysed by a glucose oxidase/peroxidase
method adapted for the Auto-analyser (10).
Insulin was determined in duplicate assays by the method of
Haies & Rändle (11) with a kit from the Radiochemical Centre,
Amersham.
All glucagon samples were assayed in triplicate by the method of
Heding (12). The reagent kit (antiserum K 5563) was obtained
from Novo Research Institute, Bagsvaerd, Denmark.
Enzyme activities were determined by kinetic semimicro methods
(total volume 1000 ) in 1-250 of liver supernatant. Liver
supernatant was prepared from 25 g/l liver homogenate (Ultra
Turrax®) in 0.15 mmol/1 KC1/2.6 mmol/1 EDTAby centrifuga-
tion at 28 000 g for 10 min. Glucose-6-phosphatase, however
was determined in whole homogenate.
Assay conditions weie äs indicated by the reference numbers:
Lactate dehy drogenase (EC 1.1.1.27) (l 3),
aspartate aminotransferase (EC 2.6.1.1) (13),
alanine aminotransferase (EC 2.6.1,2) (13),
pyruvate kinase (EC 2.7.1.40) (13),
enolase(EC 4.2.1.11) (13)
glycerol-3-phosphate dehydrogenase (EC 1.1.1.8) (14),
glucose-6-phosphate dehydrogenase (EC 1.1.1.49') (14),
hexokinase (EC 2.7.1.1) (15),
giucokinase (EC 2.7.1.2) ( 5),
fructose-6-phpsphate kinase (EC 2.7.1.11) (16),
früctose-1.6-bisphosphatase (EC 3.1.3.11) (16),
tyrosine aminptransferase (EC 2.6.1.5) (17),
glucose-6-phosphatase (EC 3.1.3.9) (18),
phosphoenol-pyruvate carboxykinase (EC 4.1.1.32) (19, 20).
Protein was determined äccording to Löwry et al. (21) and DNA
according to Hesse et al. (22).
Reageats for enzyme assay procedures were obtained from
Boehring^Mannheim GmbH,. Mannheim, and E. Merck, Darm-
stadt.
Statistical method
Student's t-test was used to test statistical significance. The
limit of significance was set to p < 0.05.
Results
The untreated, diabetic rats remained severely hyper^
glycaemic, and their rnean body weight when sacrificed,
was about half that of cpntrol rats (tab. 1). In cpntrast,
the recipients of pancreas transplants were normö-
glycaemic and had the same body weight äs the controls.
Liver weight, expressed äs fraction of body weight,, was
higher for diabetic rats than for controls (p < 0,001),
while recipient livers did not differ in weight from con-
trol livers. Liver protein and DNA concentrations were
similar in all three groups of rats (tab; 1). To minimize
variances due to differences in liver weight, enzyme ac*
tivities were expressed äs units per g protein.
Pancreas hormones
The plasma insulin concentration found in diabetic rats
was significantly (p < 0.01) below control valües, while
Tab. 1. Metabolie characterization of rats 20 weeks after pancreas transplantation.
Body weight (g)
Blood glucose (mmol/1)"1"
Plasma insulin (mU/1)
Plasma glucagon (ng/i)
Liver weight (g)
Liver weight (fraction of body weight)
Liver protein (mg/g liver weight)
Liver DNA (mg/g liver weight)
Controls
n = 12
385 ± 6
5.9 ± 0.08
11 ±0.8
40 ± 2.2
12.3 ± 0.5
0.032 ± 0.0010
154 ± 4.7
2.95 ±0.149
Recipients
n = 11
396 ± 11
5.5 ± 0.07
23 ± 4.7
63 ± 9.8
13.1 ± 0.4
0.033 ± 0.0008
146 ± 3.3
2.92 ± 0.181
Diabetics
n = 9
197 ± 12***
22.8 ± 0,6l·***
8 ± 0.5**
63 ± 10*
10.1 ± 0.3**
0.050 ± . 012*3·
145 ± 3.8
3.13 ± 0.203
Valües are given in mean ± S.E.M.
B
^°ndniUC°*S* ValUe. rePresent determinations in four monthly intervals.
**p<0.01, *** p < 0.001 vs. controls.
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glucagon was increased by almost 60% (p < 0.05).
Recipient plasma insulin was significantly (p < 0.05)
higher than in control rats, and glucagon was raised to
the same extent s in diabetic rats (tab. 1).
Glycolytic enzymes
Pyruvate kinase and glycerol 3-phosphate dehydrogenase
were significantly (p < 0.001) decreased in the diabetic
rats. The mean values for lactate dehydrogenase and
glucokinase activities were also decreased, but this did
not reach statistical significance. Following pancreas
transplantation, the previously decreased glycolytic
enzyme activities rose to control values. Only gluco-
kinase tended to remain at a low level in several rats.
Hexokinase and fructose-6-phosphate kinase activities
were equal in all three groups of rats (tab. 2).
Gluconeogenic enzymes
The activities of all gluconeogenic enzymes analysed
were enhanced in diabetic rats compared with non-
diabetic controls (not statistically significant for phos-
phoenol pyruvate carboxykinase) (tab. 2). Twenty
weeks after pancreas transplantation, all enzyme activi-
ties were decreased to values equal to those of control
rats.
Pentose phosphate pathway enzyme
Glucose-6-phosphate dehydrogenase, measured s an
indicator of the pentose phosphate pathway rate,
showed no difference in activity between diabetic,
recipient and control rats (tab. 2).
Discussion
The alterations of hepatic glucoregulatory enzyme
activities observed in the chronic streptozotocin diabetic
rats are in agreement with previous reports on the effects
of alloxan and streptozotocin induced insulin deficiency
(4-7). Some unexpected small or non-significant dif-
ferences frorn normal enzyme activity may be due to the
effect of short term starvation, which in diabetic animals
has been shown to restore enzyme activities toward
normal (5). In accordance with earlier studies (23,24),
heterotopic pancreas transplantation was followed by
peripheral hyperinsulinaemia and normogjycaemia,
whereas the diabetic hyperglucagonaemia apparently
was unaffected (tab. 1). Twenty weeks after pancreas
transplantation, the gluconeogenic and glycolytic hepatic
enzyme activities did not differ from those of healthy
control rats (tab. 2). Hexokinase activity, which is insulin
independent (25), was not affected by induction of dia-
betes or by pancreas transplantation.
In acute experimental diabetes, restoration of gluconeo-
genic and glycolytic enzyme activities toward normal
has been observed in vitro and in vivo following insulin
adrninistration (4,26,27). However, unphysiologically
high doses of insulin are required to restore normal
glucokinase activity (28) and reduce gluconeogenic
enzyme activities to normal in chronic (14 days) alloxan
diabetic rats (4). This has been attributed to the extra-
portal route of insulin administration and to the opposing
action of glucagon in the chronic diabetic and hyper-
glucagonaemic animals.
Reports on the effect of pancreas islet transplantation on
hepatic metabolism are sparse.Mzgra// et al. (29)
Tab. 2. Activities of hepatic glucoregulatory enzymes 20 weeks after pancreas transplantation.
Enzyme EC number Recipients
(n = 11)
Controls
(n = 12)
Diabetics
(n = 9)
Glycolytic enzymes
Hexokinase 2.7.1.1
Glucokinase 2.7.1.2
Fructose 6-phosphate kinase 2.7.1.11
Pyruvate kinase 2.7.1.40
Lactate dehydrogenase 1.1.1.27
Glycerol 3-phosphate dehydrogenase 1.1.1.8
Gluconeogenic enzymes
Glucose 6-phosphatase 3.1.3.9
Fructose 1.6-bLsphosphatase 3.1.3.11
Phosphoenolpyruvate carboxykinase 44-1-32
Enolase 4.2.1.11
Aspartate aminotransferase 2.6.1.1
Alanine aminotransferase 2.6.1.2
Tyrosine aminotransferase 2.6.1.5
Pentose phosphate pathway enzyme
Glucose 6-phosphate dehydrogenase l. l .1.49
0.77 ± 0.18
2.71 ± 0.69
5.59 ± 0.58
181 ±11.2
2107 ± 71
252 ± 6.6
116
43.8
94.8
101
731
340
15.5
± 6.6
± 2.4
i 4.4
± 5.37
±44
±16.3
± 2.35
0.78 ± 0.16
4.00 ± 0.64
5.58 ± 0.52
186 ± 13.6
2090 ± 118
270 ± 10.5
117
47.7
97.2
100
745
376
13.8
9.1
2.2
7.9
9.96
31
15.6
1.10
0.75 ± 0.19 N.S.
2.78 ± 0.85 N.S.
5.93 ± 0.77 N.S.
112 ± 6.1***
1780 ±158 N.S.
169 ± 7.5***
170
56.3
117
145
1422
518
24.7
8.0***
3.0*
12.4 N.S.
10.1**
86***
33.6***
2.38***
8.14 ± 0.88 7.61 ± 0.85 7.11 ± 0.36 N.S.
Enzyme activities expressed in μιηοΐ/min · g protein (mean ± SEM)
N. S. not significant * p < 0.05, ** p < 0.01, *** p < 0.001 v. s. controls
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reported normalization of glucokinase and pyruvate
kinase following intraperitoneal transplantation of
islets in streptozotocin-diabetic rats, whereas Selawry
et al. (30), found incomplete normalization of gluconeo-
genesis in recipients of intrahepatic transplanted islets.
Studies on the effect of pancreas organ transplantation
on hepatic glucoregulatory enzymes have previously not
been published.
The peripheral hyperinsulinaemia observed in the pan-
creas recipients of the present study may be ascribed to
the extraportal release of insulin from the transplant,
directly into the systemic circulation. The portal con-
centrations of insulin and glucagon were examined in a
separate study, vvhich demonstrated a significantly
decreased portal insulin to glucagon ratio in recipients
of heterotopic pancreas transplants (9). The important
role of glucagon in the regulation of hepatic carbo-
hydrate metabolism has been demonstrated in numerous
in vivo and in vitro studies (27, 31), and a significant
correlation between the relative concentrations of
insulin and glucagon in portal blood and the glucose
productiori rate has been reported (31). However, results
of sustained infusions of glucagon have indicated a
transient effect of this hormone on hepatic metabolism
(32).
The results of the present study show that the hetero-
topic pancreas transplant restores normal Kepatic glu*
coneogenie and glycolytic activities in chronic streptozo-
tocin-diabetic rats despite chronic hypeirglucagonaemia.
The results support the Suggestion that glucagon has only
an evanescent effect on hepatic metabolism when suffi-
cient insulin is available.
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